Wealth Enhancement Advisory Services
KURA icon

Wealth Enhancement Advisory Services’s Kura Oncology KURA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Buy
159,724
+43,682
+38% +$412K ﹤0.01% 1741
2026
Q1 		$849K Buy
116,042
+735
+0.6% +$6.31K ﹤0.01% 1920
2025
Q4 		$1.1M Buy
115,307
+24,252
+27% +$254K ﹤0.01% 1894
2025
Q3 		$859K Buy
91,055
+34,143
+60% +$243K ﹤0.01% 1962
2025
Q2 		$334K Buy
56,912
+35,779
+169% +$219K ﹤0.01% 2560
2025
Q1 		$139K Buy
+21,133
New +$165K ﹤0.01% 2699

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Wealth Enhancement Advisory Services's KURA Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Kura Oncology (KURA) stake by 38% in Q2 2026, buying an estimated $412K and bringing the position to 159,724 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

Wealth Enhancement Advisory Services first reported a position in KURA in Q1 2025 and has held it in 6 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Wealth Enhancement Advisory Services held 159,724 shares of Kura Oncology worth $1.57M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 43,682 Kura Oncology shares in Q2 2026, an estimated $412K.
  • Kura Oncology made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1741 holding.
  • Wealth Enhancement Advisory Services first reported a position in Kura Oncology in Q1 2025 and has held it in 6 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.